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Abstract
Background: Patients admitted to emergency departments with traumatic brain injury (TBI) are commonly being
treated with oral anticoagulants. In contrast to patients without anticoagulant medication, no guidelines, scores or
recommendations exist for the management of mild traumatic brain injury in these patients. We therefore tested
whether age as one of the high risk factors of the Canadian head CT rule is applicable to a patient population on
oral anticoagulants.
Methods: This cross-sectional analysis included all patients with mild TBI and concomitant oral anticoagulant
therapy admitted to the Emergency Department, Inselspital Bern, Switzerland, from November 2009 to October
2014 (n = 200). Using a logistic regression model, two groups of patients with mild TBI on oral anticoagulant
therapy were compared — those with and those without intracranial haemorrhage.
Results: There was no significant difference in age between the patient groups with (n = 86) and without (n = 114)
intracranial haemorrhage (p = 0.078).
In univariate logistic regression, GCS (OR = 0.419 (0.258; 0.680)) and thromboembolic event as reason for anticoagulant
therapy (OR = 0.486 (0.257; 0.918)) were significantly associated with intracranial haemorrhage in patients with mild TBI
and anticoagulation (all p < 0.05). However, there was no association with age (p = 0.078, OR = 1.024 (0.997; 1.051)), the
type of accident or additional medication with acetylsalicylic acid or clopidogrel ((both p > 0.05; 0.552 (0.139; 2.202) and
0.256 (0.029; 2.237), respectively).
Conclusion: Our study found no association between age and intracranial bleeding. Therefore, until further risk factors
are identified, diagnostic imaging with CCT remains necessary for mild TBI patients on oral anticoagulation of all ages,
especially those with therapeutic anticoagulation because of thromboembolic events.
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Background
Traumatic brain injuries (TBI) are very common in
emergency department admissions, with more than one
million admissions per year in the USA alone [1, 2]. The
case definitions of traumatic brain injury and even more
so the definition of mild traumatic brain injury in the lit-
erature is very heterogeneous. We have now followed
the definition of TBI as “an alteration in brain function,
or other evidence of brain pathology, caused by an exter-
nal force” [3].
Many studies have found that approx. 10–15 % of pa-
tients with head injuries and a Glasgow Coma Scale
(GCS) of 15 exhibit bleeding that is detectable in the cra-
nial computer tomogram (CCT) [4, 5]. In this population,
fewer than 1 % of patients with bleeding are submitted to
neurosurgical intervention for mild traumatic brain injury
[4–7]. Although few cases of major intracranial haemor-
rhage are diagnosed via CCT imaging in this group of pa-
tients, this radiographic imaging is a standard diagnostic
procedure. One American study has reported a marked
increase in CCT in recent years [8]. Many guidelines and
scores for the management of patients with mild trau-
matic brain injury try to limit the use of CCT to evidence
based indications [4, 9].
For patients with risk factors such as anticoagulant
medication, knowledge is limited, but approximately
20 % of these patients develop intracranial haemorrhage
(ICH) [10]. Several studies have previously shown that in
anticoagulated patients the risk for intracranial haemor-
rhage generally increases with age [11–13].
Neither the “Canadian CT Head Rule” nor the “New
Orleans Criteria” apply to patients on anticoagulants
[4, 9]. The clinical policy statement on “Neuroimaging
and decision-making in adult mild traumatic brain in-
jury in the acute setting” from the American College
of Emergency Physicians (2008) states that the man-
agement of patients on anticoagulants is unclear and
gives no specific recommendations [10]. In the 2014
review of the NICE guideline on head injury (No. 176), a
CT head scan within 8 h of the injury is recommended for
all patients on warfarin treatment, even without other
clear indications for a CCT [14]. No data is provided for
the observation period or whether these patients should
be admitted to hospital. For patients on antiplatelet
therapy, such as acetylsalicylic acid or clopidogrel,
there are retrospective studies which suggest that
there is an increased risk for intracranial bleeding in
trauma patients [15, 16].
Another study investigated the impact of age in com-
parison to anticoagulation and found that more older
patients needed neurosurgical intervention than patients
taking anticoagulants [17].
In contrast to most studies on patients on oral anticoag-
ulants (acetylsalicylic acid or clopidogrel) or on warfarin,
more recent studies try to differentiate between oral
anticoagulants and give specific recommendations. A
recent study found that low dose acetylsalicylic acid
is not associated with progression of initial haemor-
rhagic stroke or clinical deterioration [18]. However,
another study detected an increased rate of neurosurgical
interventions and clinical deterioration in patients on pre-
trauma clopidogrel [19].
We hypothesized that age may not be associated with
ICH in anticoagulated patients with mild TBI and there-
fore tested whether age as one of the high risk factors of
the Canadian head CT rule is a risk factor for ICH in a
patient population with mild traumatic brain injury on
oral anticoagulants.
Methods
This cross-sectional study included 260 patients on oral
anticoagulant (OAC) therapy and with traumatic brain
injury (TBI), defined as trauma to the head combined
with loss of consciousness, amnesia and vegetative symp-
toms, who were admitted to the Emergency Department
of the Inselspital between November 1, 2009, and October
31, 2014. Within this period, medical records were
screened for “rivaroxaban” (Xarelto), “apixaban” (Eliquis)
and “dabigatran” (Pradaxa) as well as “phenprocoumon”
(Marcoumar). Patients with prehospital use of these medi-
cations and the documented diagnosis of traumatic brain
injury were included. In order to minimise selection bias,
we excluded patients transferred to our Level 1 hospital
from other hospitals. Patients with an INR <2 under phen-
procoumon at admission were also excluded.
Oral anticoagulation (OAC) was defined as medication
with phenprocoumon or any new direct oral anticoagulants
(DOAC), such as rivaroxaban, apixaban or dabigatran.
Data were collected on age, gender, nationality, pri-
mary outcome, traumatic brain injury, type of accident,
medication, indication for oral anticoagulation, intracra-
nial haemorrhage and location of bleeding, as well as the
initial and lowest values of the Glasgow Coma Scale
(GCS). Blood parameters monitored on admission were
also registered (creatinine, INR).
The study protocol was approved and registered with
the Ethics Committee of the Canton Bern, Switzerland.
Because of the retrospective design of this cross-sectional
study with anonymised data, a waiver for informed con-
sent was issued.
Statistical analysis
We compared patients on oral anticoagulant therapy
with and without intracranial haemorrhage, with respect
to age, GCS, creatinine and INR on admission by means
of a Mann-Whitney U test. The risk for ICH in patients
younger or older than age 65 was assessed via Chi-
square test. Influences of different variables on intracranial
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haemorrhage were investigated with a logistic regres-
sion model for univariate tests.
All calculations were performed with the SPSS Statistics
21 (IBM Coorp.) program. A two tailed p value of less
than 0.05 was considered statistically significant.
Results
Overall 8886 patients had medical records with “Rivar-
oxaban”, “Apixaban”, “Dabigatran” or “Phenprocoumon”.
Two hundred and sixty (260) of these patients had been
admitted with the diagnosis of traumatic brain injury
while currently on oral anticoagulation (OAC). The
baseline characteristics of the patients included are
shown in Table 1. As only a few of these patients were
on the new DOACs (n = 19) rather than the classical
phenprocoumon, statistical comparison of those groups
was not meaningful.
The numbers of our patients with traumatic brain injury
and mild TBI (defined as GCS 13–15, n = 200), moderate
TBI (GCS 9–12, n = 25) and severe TBI (GCS <9, n = 26)
and also the number of patients with and without intra-
cranial haemorrhage (ICH) are shown in Fig. 1. Overall, 8
(3.1 %) patients were on clopidogrel and 16 (6.2 %)
patients on acetylsalicylic acid in combination with
OAC therapy (Table 1). Table 1 lists the reasons for
oral anticoagulation in patients with TBI.
For further evaluation we focused on patients with
mild TBI, as patients with moderate and severe TBI need
CT irrespective of age and coagulation status.
Mann-Whitney U tests were used to compare patient
groups with (n = 86) and without (n = 114) ICH; the
group with ICH exhibited lower GCS, as well as lower
creatinine (Table 2, p < 0.05). There was no difference in
age and INR between those groups (Table 2, p = 0.072,
respectively p = 0.187). In particular there was no sig-
nificant difference between mild TBI patients younger
than 65 years and patients 65 years or older regarding
ICH (p = 0.816). In the group of patients with mild
TBI, 21 patients were younger than 65 years and 179
patients over 65 years.
Univariate logistic regression analysis revealed that
GCS (p < 0.001, OR = 0.419 (0258; 0.680)) is associated
with ICH in patients with mild TBI (Table 3). In
addition, a thromboembolic event (p = 0.026, OR = 0.486
(0.257; 0.918)) as the reason for anticoagulant therapy
was significantly associated with ICH (Table 3). In pa-
tients with mild TBI, ICH was not associated with age
(p = 0.078, OR = 1.024 (0.997; 1.051)), the type of acci-
dent or additional medication with acetylsalicylic acid or
clopidogrel (OR = 0.552 (0.139; 2.202) OR = 0.256 (0.029;
2.237), respectively) (Table 3).
Discussion
Our study demonstrates that age is not associated with
ICH in patients on oral anticoagulants and with mild
traumatic brain injury who were admitted as emergencies.
However, thromboembolic events as indication for the
Table 1 Baseline characteristics of all patients with traumatic brain injury taking OAC
Parameter OAC DOAC Phenprocoumon
n = 260 n = 19 n = 241
Age (years) 79.0 ± 11.3 73.7 ± 13.4 79.7 ± 11.1
Gender (male; female) 67 (25.8 %); 193 (74.2 %) 10 (52.6 %); 9 (47.4 %) 57 (23.7 %); 184 (76.3 %)
Indication
Atrial fibrillation 130 (50.0 %) 8 (42.1 %) 122 (50.6 %)
Thromboembolic event 71 (27.3 %) 9 (47.4 %) 62 (25.7 %)
Prophylaxis post-surgery 2 (0.8 %) 2 (10.5 %) 0 (0 %)
Mechanical heart valve 16 (6.2 %) 0 (0 %) 16 (6.6 %)
Indication unclear 41 (15.8 %) 0 (0 %) 41 (17.0 %)
Additional medication
Acetylsalicylic acid 16 (6.2 %) 1 (5.3 %) 15 (6.2 %)
Clopidogrel 8 (3.1 %) 2 (10.5 %) 6 (2.5 %)
Intracranial haemorrhage general 138 (53.1 %) 7 (36.8 %) 131 (54.4 %)
Epidural bleeding 9 (3.5 %) 0 (0 %) 9 (3.7 %)
Subdural bleeding 89 (34.2 %) 1 (5.3 %) 88 (36.5 %)
Subarachnoidal bleeding 39 (15.0 %) 3 (15.8 %) 36 (14.9 %)
Intracerebral bleeding 34 (13.1 %) 3 (15.8 %) 31 (12.9 %)
Definitions: Oral anticoagulation (OAC) =medication with phenprocoumon or direct oral anticoagulation (DOAC) with rivaroxaban, apixaban or dabigatran
Mean ± Standard deviation or absolute numbers (%)
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oral anticoagulation are a risk factor for ICH in this pa-
tient group.
Age as a risk factor for ICH has been well studied in
different populations with and without trauma and with-
out anticoagulation: A recent meta-analysis of patients
with non-traumatic and traumatic ICH in patients with
non-ST-elevation myocardial infarction found that age is
associated with an increased rate of ICH in this special
patient population [20]. Large studies of TBI patients
from Spain and Italy without anticoagulation therapy in-
vestigated different variables for the prediction of ICH
and showed that age is associated with ICH [7, 21]. This
is reflected in clinical guidelines and decision rules about
the need for CCT scans in patients with minor TBI. The
New Orleans criteria define age >60 years and the Can-
adian CT head rule age >65 years as strong risk factors
and therefore recommend a CCT [4, 9]. In contrast to
this, age was not associated with ICH in our study of
mild TBI patients with OAC. Because of this, it is not
possible to conclude that younger patients on anticoagu-
lants are at low risk of ICH.
A further risk factor that could be demonstrated in
our population was the indication of a thromboembolic
event. It may be speculated that patients with this
Fig. 1 Patient assignment to the different subgroups of TBI
Table 2 Comparison of patient groups with intracranial
bleeding (n = 86) and without intracranial bleeding (n = 114)
among patients with mild traumatic brain injury (n = 200 in
total)
Parameter Intracranial bleeding No intracranial bleeding p
n = 86 n = 114
Age 80.2 ± 10.3 77.3 ± 11.8 0.127
GCS 14.4 ± 0.7 14.8 ± 0.5 <0.001*
Creatinine 95.5 ± 41.5 103.7 ± 35.2 0.036*
INR 2.79 ± 0.97 2.66 ± 1.40 0.187
Mean; ±Standard deviation, Mann-Whitney U, p < 0.05*
GCS glasgow coma scale, INR international normalised ratio
Table 3 Associations of intracranial bleeding in patients with
mild traumatic brain injury (n = 200) with different parameters in
univariate analysis
Parameter p Odds ratio (confidence interval)
Age 0.078 1.024 (0.997; 1.051)
GCS <0.001* 0.419 (0.258; 0.680)
Creatinine 0.214 0.994 (0.985; 1.003)
INR 0.528 1.092 (0.830; 1.438)
Gender 0.869 1.056 (0.554; 2.013)
Indication
Atrial fibrillation 0.414 1.263 (0.721; 2.213)
Thromboembolic event 0.026* 0.486 (0.257; 0.918)
Mechanical heart valve 0.417 1.595 (0.516; 4.929)
Additional medication
Acetylsalicylic acid 0.400 0.552 (0.139; 2.202)
Clopidogrel 0.218 0.256 (0.029; 2.237)
Type of accident
Road traffic accident 0.934 0.960 (0.369; 2.501)
Fall 0.451 1.397 (0.586; 3.332)
Direct trauma 0.317 0.324 (0.036;2.948)
Univariate logistic regression, p < 0.05*
GCS glasgow coma scale, INR international normalized ratio
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indication exhibit better compliance and are more
closely monitored by their physicians than when the
anticoagulation is only prescribed for prophylactic indi-
cations like atrial fibrillation. Patients with a prior
thromboembolic event may take higher doses of anti-
coagulant and be at greater risk of ICH.
As this study was retrospective and involved the
screening of medical records, it is possible that some
cases were missed. Although we excluded secondary
transport to our Level 1 university centre, selection bias
from selective admission to our emergency department
might be possible.
Conclusion
Few factors are known to predict intracranial haemorrhage
in patients with oral anticoagulation. Our study showed no
association between age and intracranial bleeding. There-
fore, diagnostic imaging with CCT is still necessary for pa-
tients of all ages with mild TBI, especially with therapeutic
anticoagulation because of thromboembolic events as
nearly half of anticoagulated patients with mild TBI had
ICH on CCT.
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